Form 4 holding
Chief Financial & Business Officer
4D Molecular Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 130,000
- Estimated value
- Report date
- 06 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount